Vas Narasimhan

28.06.2022 • News

Novartis Pledges to Fight Tropical Diseases and Malaria

Swiss drugmaker Novartis has made a five-year financial commitment of $250 million to fight neglected tropical diseases (NTDs) and malaria.

Top-Feature

Bio-Rad Laboratories

ECA Foundation Aims to Become Largest Pharma Association for GMP/GDP Compliance

Free Expert Insights

Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Novartis Pharma GmbH

Vas Narasimhan

Novartis Pledges to Fight Tropical Diseases and Malaria

Top-Feature

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

20 Years of CHEManager International

Advanced Recycling Conference 2025: New Paths to the Circular Economy

A successful concept on course for expansion — maintenance Munich 2025

ECA Foundation Aims to Become Largest Pharma Association for GMP/GDP Compliance

Free Expert Insights

Dual‑Targeting Breakthroughs

Newsletter & e-edition